Insider · CIK 0001766522

BALL BRYAN

Reports to the SEC for 3 companies · MORRISTOWN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001766522

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	See remarks	AAward	+91.6K sh	—	—	91,633
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	See remarks	AAward	+91.6K sh	—	—	91,633
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	See remarks	AAward	+91.6K sh	—	—	91,633
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	See remarks	AAward	+91.6K sh	—	—	91,633
2026-05-14	WHWKWhitehawk Therapeutics, Inc.A Award	See remarks	AAward	+51K sh	$3.92	+$200K	448,126
2026-04-14	WHWKWhitehawk Therapeutics, Inc.S Sale	See remarks	SSale	−92.5K sh	$3.64	−$337K	397,106
2026-04-13	WHWKWhitehawk Therapeutics, Inc.S Sale	See remarks	SSale	−26.4K sh	$3.46	−$91.3K	489,566
2026-04-10	WHWKWhitehawk Therapeutics, Inc.S Sale	See remarks	SSale	−6,596 sh	$3.43	−$22.6K	515,955
2026-04-09	WHWKWhitehawk Therapeutics, Inc.S Sale	See remarks	SSale	−50K sh	$3.57	−$179K	522,551
2026-04-01	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	See remarks	AAward	+250K sh	—	—	250,058
2026-04-01	WHWKWhitehawk Therapeutics, Inc.M Exercise/Conversion	See remarks	MExercise/Conversion	+367K sh	—	—	572,551
2026-04-01	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	See remarks	MExercise/Conversion	−367K sh	—	—	0
2026-03-02	WHWKWhitehawk Therapeutics, Inc.S Sale	See remarks	SSale	−1,834 sh	$3.31	−$6,069.806	206,019
2026-03-01	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	See remarks	MExercise/Conversion	−5,000 sh	—	—	10,000
2026-03-01	WHWKWhitehawk Therapeutics, Inc.M Exercise/Conversion	See remarks	MExercise/Conversion	+5,000 sh	—	—	207,853
2025-04-01	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	See remarks	AAward	+367K sh	—	—	366,532
2025-04-01	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	See remarks	AAward	+367K sh	—	—	366,532
2025-03-04	WHWKWhitehawk Therapeutics, Inc.A Award	See remarks	AAward	+100K sh	$2.40	+$240K	202,853
2025-03-03	WHWKWhitehawk Therapeutics, Inc.S Sale	See remarks	SSale	−2,147 sh	$2.35	−$5,045.45	102,853
2025-03-01	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	See remarks	MExercise/Conversion	−5,000 sh	—	—	15,000
2025-03-01	WHWKWhitehawk Therapeutics, Inc.M Exercise/Conversion	See remarks	MExercise/Conversion	+5,000 sh	—	—	105,000
2022-07-11	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Qual. Officer & SVP Ops.	FTax Payment	−436 sh	$14.57	−$6,352.52	25,178
2022-04-11	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Qual. Officer & SVP Ops.	FTax Payment	−531 sh	$17.19	−$9,127.89	25,614
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	Chief Qual. Officer & SVP Ops.	AAward	+3,600 sh	—	—	26,145
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Chief Qual. Officer & SVP Ops.	AAward	+6,100 sh	—	—	6,100
2022-01-11	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Qual. Officer & SVP Ops.	FTax Payment	−2,455 sh	$16.83	−$41.3K	22,545
2021-01-11	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Chief Qual. Officer & SVP Ops.	AAward	+39.2K sh	—	—	39,185
2021-01-11	INTERCEPT PHARMACEUTICALS, INC.A Award	Chief Qual. Officer & SVP Ops.	AAward	+25K sh	—	—	25,000
2020-10-23	IMMUNOMEDICS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Quality Officer	DDisposition to Issuer	−262K sh	—	—	0
2020-10-23	IMMUNOMEDICS INCD Disposition to Issuer	Chief Quality Officer	DDisposition to Issuer	−10K sh	—	—	0
2020-03-04	IMMUNOMEDICS INCStock Option (right to buy)A Award	Chief Quality Officer	AAward	+51.6K sh	—	—	51,600
2019-10-03	IMMUNOMEDICS INCP Purchase	Chief Quality Officer	PPurchase	+5,000 sh	$14.18	+$70.9K	10,000
2019-09-10	IMMUNOMEDICS INCStock Option (right to buy)A Award	Chief Quality Officer	AAward	+10.4K sh	—	—	10,440
2019-09-06	IMMUNOMEDICS INCStock Option (right to buy)A Award	Chief Quality Officer	AAward	+57K sh	—	—	57,040
2019-06-20	IMMUNOMEDICS INCP Purchase	Chief Quality Officer	PPurchase	+5,000 sh	$13.35	+$66.8K	5,000
2019-03-05	IMMUNOMEDICS INCStock Option (right to buy)A Award	Chief Quality Officer	AAward	+143K sh	—	—	142,857

Recent filings

Accepted (ET)
Sep 184/A
BALL BRYAN0001766522-26-000017
SEC(opens sec.gov)
Sep 154
BALL BRYAN0001766522-26-000015
SEC(opens sec.gov)
May 184
BALL BRYAN0001766522-26-000013
SEC(opens sec.gov)
Apr 154
BALL BRYAN0001766522-26-000011
SEC(opens sec.gov)
Apr 134
BALL BRYAN0001766522-26-000009
SEC(opens sec.gov)
Apr 34
BALL BRYAN0001766522-26-000005
SEC(opens sec.gov)
Mar 104
BALL BRYAN0001766522-26-000002
SEC(opens sec.gov)
Apr 34
BALL BRYAN0001415889-25-010080
SEC(opens sec.gov)
Mar 44
BALL BRYAN0001415889-25-006676
SEC(opens sec.gov)

Companies

Address

C/O WHITEHAWK THERAPEUTICS, INC. 2 HEADQUARTERS PLAZA, EAST BUILDING, 11T

MORRISTOWN, NJ, 07960